Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Seres Therapeutics Inc MCRB

Healthcare Biotechnology
Seres Therapeutics, Inc. is a commercial-stage microbiome therapeutics company. It is focused on the development and commercialization of a novel class of biological drugs, which are designed to treat disease by modulating the microbiome to restore health by repairing the function of a disrupted microbiome to a non-disease state. Its lead program, VOWST, is to prevent recurrence of... see more

Recent & Breaking News (NDAQ:MCRB)

DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Seres Therapeutics, Inc. (MCRB) & Lead Plaintiff Deadline: November 29, 2016

GlobeNewswire November 22, 2016

MCRB SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Seres Therapeutics, Inc. and a Lead Plaintiff Deadline of November 28, 2016

Business Wire November 18, 2016

MCRB INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Seres Therapeutics, Inc. and a Lead Plaintiff Deadline of November 28, 2016

PR Newswire November 14, 2016

Seres Therapeutics Reports Third Quarter 2016 Financial Results and Provides Operational Progress Update

Business Wire November 10, 2016

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Seres Therapeutics, Inc. - MCRB

GlobeNewswire November 9, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Seres Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 28, 2016

Business Wire November 9, 2016

MCRB SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Seres Therapeutics, Inc. and a Lead Plaintiff Deadline of November 28, 2016

Business Wire November 4, 2016

Seres Therapeutics to Host Third Quarter 2016 Financial Results and Operational Progress Conference Call and Webcast on November 10, 2016

Business Wire November 4, 2016

The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Seres Therapeutics, Inc. Investors and Encourages Investors to Contact the Firm

Business Wire November 1, 2016

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Seres Therapeutics, Inc. To Contact The Firm Before Lead Plaintiff Deadline

PR Newswire October 31, 2016

Seres Therapeutics, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors

Business Wire October 31, 2016

MCRB INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Seres Therapeutics, Inc. and a Lead Plaintiff Deadline of November 28, 2016

GlobeNewswire October 31, 2016

Lifshitz & Miller Law Firm Announces Investigation of Global Digital Solutions Inc., LifeVantage Corporation, New York REIT, Inc., Pilgrim's Pride Corporation, Sanderson Farms, Inc., Seres Therapeutics, Inc., Taubman Centers, Inc., and Xerox Corporation

PR Newswire October 28, 2016

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Seres Therapeutics, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 28, 2016 – MCRB

GlobeNewswire October 26, 2016

Rosen Law Firm Reminds Seres Therapeutics, Inc. Investors of Important November 28 Deadline in Lawsuit - MCRB

Business Wire October 26, 2016

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Seres Therapeutics, Inc. (MCRB) & Lead Plaintiff Deadline: November 29, 2016

GlobeNewswire October 19, 2016

Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Seres Therapeutics, Inc.

PR Newswire October 13, 2016

MCRB LOSS NOTICE: Rosen Law Firm Reminds Seres Therapeutics, Inc. Investors of Important Deadline in Lawsuit - MCRB

PR Newswire October 11, 2016

Robbins Arroyo LLP: Seres Therapeutics, Inc. (MCRB) Misled Shareholders According to a Recently Filed Class Action

Business Wire October 7, 2016

Glancy Prongay & Murray Commences Investigation on Behalf of Seres Therapeutics, Inc. Investors

Business Wire October 7, 2016